Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 15 | 2022 | 49 | 4.330 |
Why?
|
| Crohn Disease | 7 | 2022 | 55 | 3.140 |
Why?
|
| Proctocolectomy, Restorative | 12 | 2017 | 18 | 2.950 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2023 | 85 | 2.560 |
Why?
|
| Colon | 3 | 2021 | 98 | 1.660 |
Why?
|
| alpha-Defensins | 2 | 2021 | 15 | 1.420 |
Why?
|
| Proteomics | 5 | 2021 | 302 | 1.160 |
Why?
|
| Intestinal Mucosa | 5 | 2017 | 115 | 1.110 |
Why?
|
| Colonic Pouches | 3 | 2011 | 7 | 1.080 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 10 | 0.940 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 413 | 0.910 |
Why?
|
| Colitis | 1 | 2022 | 64 | 0.810 |
Why?
|
| Enterotoxins | 1 | 2021 | 32 | 0.790 |
Why?
|
| Organoids | 1 | 2021 | 20 | 0.780 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 181 | 0.540 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2015 | 100 | 0.530 |
Why?
|
| Ileostomy | 3 | 2006 | 5 | 0.520 |
Why?
|
| alpha-Globins | 1 | 2014 | 3 | 0.520 |
Why?
|
| Precancerous Conditions | 2 | 2011 | 81 | 0.440 |
Why?
|
| Adenocarcinoma | 2 | 2011 | 239 | 0.410 |
Why?
|
| Mucous Membrane | 1 | 2010 | 34 | 0.380 |
Why?
|
| Humans | 21 | 2023 | 34853 | 0.380 |
Why?
|
| Anus Neoplasms | 1 | 2011 | 47 | 0.370 |
Why?
|
| Proteome | 1 | 2010 | 132 | 0.350 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2009 | 20 | 0.350 |
Why?
|
| Postoperative Complications | 1 | 2009 | 206 | 0.310 |
Why?
|
| Gastrointestinal Hormones | 1 | 2007 | 2 | 0.310 |
Why?
|
| Blood Proteins | 2 | 2015 | 65 | 0.300 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 416 | 0.300 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 13 | 0.300 |
Why?
|
| Prostatic Hyperplasia | 1 | 2006 | 33 | 0.290 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 26 | 0.290 |
Why?
|
| Antioxidants | 2 | 2023 | 386 | 0.280 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 48 | 0.280 |
Why?
|
| Electrolytes | 1 | 2006 | 25 | 0.280 |
Why?
|
| Liver Diseases | 1 | 2006 | 31 | 0.280 |
Why?
|
| Aged | 6 | 2021 | 6448 | 0.270 |
Why?
|
| Lipids | 1 | 2006 | 222 | 0.250 |
Why?
|
| Male | 13 | 2021 | 18870 | 0.240 |
Why?
|
| Peptides | 1 | 2006 | 308 | 0.240 |
Why?
|
| Haptoglobins | 1 | 2023 | 9 | 0.240 |
Why?
|
| Deferoxamine | 1 | 2023 | 19 | 0.240 |
Why?
|
| Retrospective Studies | 2 | 2021 | 1961 | 0.230 |
Why?
|
| Adenomatous Polyposis Coli | 3 | 2007 | 27 | 0.230 |
Why?
|
| Middle Aged | 10 | 2014 | 9642 | 0.230 |
Why?
|
| Erythrocytes | 1 | 2023 | 107 | 0.220 |
Why?
|
| Adolescent | 7 | 2014 | 5035 | 0.220 |
Why?
|
| Female | 11 | 2021 | 19873 | 0.210 |
Why?
|
| Prostatic Neoplasms | 2 | 2008 | 794 | 0.210 |
Why?
|
| Mucin-6 | 1 | 2021 | 6 | 0.200 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 99 | 0.200 |
Why?
|
| Cell Lineage | 1 | 2021 | 88 | 0.190 |
Why?
|
| Pouchitis | 2 | 2011 | 4 | 0.190 |
Why?
|
| Adult | 9 | 2015 | 11034 | 0.180 |
Why?
|
| Immunoglobulins | 1 | 2000 | 36 | 0.180 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 43 | 0.180 |
Why?
|
| Macrophages | 1 | 2023 | 431 | 0.180 |
Why?
|
| Triglycerides | 1 | 2000 | 129 | 0.180 |
Why?
|
| Gastric Acid | 1 | 1999 | 8 | 0.180 |
Why?
|
| Gastrins | 1 | 1999 | 9 | 0.180 |
Why?
|
| Chronic Disease | 1 | 2022 | 469 | 0.170 |
Why?
|
| Cholesterol | 1 | 2000 | 194 | 0.170 |
Why?
|
| Logistic Models | 1 | 2021 | 894 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2021 | 366 | 0.160 |
Why?
|
| Muramidase | 1 | 2017 | 18 | 0.160 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 964 | 0.150 |
Why?
|
| Biopsy | 1 | 2017 | 151 | 0.150 |
Why?
|
| Cells, Cultured | 1 | 2021 | 1442 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 211 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2006 | 26 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2015 | 834 | 0.130 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Clusterin | 1 | 2015 | 9 | 0.130 |
Why?
|
| Ceruloplasmin | 1 | 2015 | 15 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 859 | 0.130 |
Why?
|
| Peptide Mapping | 2 | 2015 | 19 | 0.130 |
Why?
|
| Comet Assay | 1 | 2014 | 72 | 0.130 |
Why?
|
| Anemia | 1 | 1994 | 45 | 0.120 |
Why?
|
| Prognosis | 2 | 2014 | 707 | 0.120 |
Why?
|
| Young Adult | 2 | 2014 | 4012 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 600 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 73 | 0.120 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 16 | 0.120 |
Why?
|
| Hemoglobins | 2 | 2009 | 101 | 0.120 |
Why?
|
| DNA Damage | 1 | 2014 | 341 | 0.110 |
Why?
|
| Risk Factors | 2 | 2011 | 3414 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 818 | 0.100 |
Why?
|
| Discriminant Analysis | 1 | 2010 | 23 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 166 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2009 | 4 | 0.090 |
Why?
|
| Folic Acid Deficiency | 1 | 2009 | 6 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2011 | 231 | 0.090 |
Why?
|
| Transferrin | 1 | 2009 | 31 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2006 | 1353 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 874 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2333 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 882 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 133 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2006 | 8 | 0.070 |
Why?
|
| Hematology | 1 | 2006 | 3 | 0.070 |
Why?
|
| Quality of Life | 1 | 2009 | 459 | 0.060 |
Why?
|
| Prevalence | 1 | 2009 | 1425 | 0.060 |
Why?
|
| Child | 2 | 2015 | 2875 | 0.060 |
Why?
|
| Liver | 1 | 2006 | 447 | 0.060 |
Why?
|
| Greece | 1 | 2015 | 18 | 0.030 |
Why?
|
| Schilling Test | 1 | 1994 | 1 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 1994 | 5 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 98 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 1994 | 19 | 0.030 |
Why?
|
| Folic Acid | 1 | 1994 | 46 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1994 | 10 | 0.030 |
Why?
|
| Preoperative Care | 1 | 1994 | 25 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1994 | 18 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 1994 | 19 | 0.030 |
Why?
|
| Iron | 1 | 1994 | 204 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 608 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 91 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 138 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2008 | 56 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 555 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1056 | 0.020 |
Why?
|